Founder, CEO, and Chairman Chris Boyle is an experienced entrepreneur and engineer who holds 42 issued U.S. patents across a myriad of fields, with additional patents pending. (creditdonkey.com)
The Food and Drug Administration Modernization Act of 1997 provided companies six months of additional patent protection for every drug they tested in children, and after that, a nascent pediatric clinical trial infrastructure began taking shape. (scientificamerican.com)
The same legislation also provides for the granting of supplementary protection certificates (SPCs), which give additional patent protection of up to five years where there has been a regulatory delay in allowing patented medicines to be sold on the EU market. (cigionline.org)